Dr. Suri Moonsamy

Suri Moonsamy is a researcher in HIV prevention and treatment whose work bridges molecular drug discovery and public health implementation in sub-Saharan Africa. Affiliated with leading clinical research networks in the region, Moonsamy has contributed to studies addressing HIV risk, transmission dynamics, and therapeutic optimization, with a strong focus on women and high-burden communities.

Early scholarship centered on computational drug design targeting HIV proteins such as reverse transcriptase, CCR5, and Nef, elucidating resistance mechanisms and informing inhibitor development. This mechanistic expertise evolved into population-level investigations of HIV incidence, including risk prediction tools and analyses of structural and behavioral determinants among young women in KwaZulu-Natal.

Recent contributions emphasize implementation science and clinical effectiveness, including research on the dapivirine vaginal ring for prevention and optimized dolutegravir dosing during tuberculosis co-treatment. Across these areas, the work demonstrates strength in translating molecular insights and epidemiologic evidence into strategies that advance equitable, evidence-based HIV care and prevention.